Target intelligence / Profile preview

ALMS1 pseudogene 1 (ALMS1P1)

Target
ALMS1P1
Molecular classification
Other (Pseudogene)
01

Overview

ALMS1 pseudogene 1 (ALMS1P1) is a genomic sequence derived from the ALMS1 gene, but unlike ALMS1, it does not encode a functional protein. Pseudogenes generally arise from gene duplication or retrotransposition events and are often transcriptionally silent, although some may produce non-coding RNAs. ALMS1P1 shares sequence similarity with the active ALMS1 gene, whose protein product is localized to centrosomes and basal bodies and plays roles in ciliary function, intracellular trafficking, and metabolic regulation[7]. Mutations in the functional ALMS1 gene—not the pseudogene—result in Alström syndrome, a complex disorder characterized by obesity, diabetes, neurosensory deficits, and multi-organ involvement[1][2][4]. There is no evidence that ALMS1P1 acts as a drug target, biomarker, or has direct biological or pathological function. Key points: - ALMS1P1 is a pseudogene, not a protein-coding gene[7]. - The clinically relevant target is ALMS1, not ALMS1P1. - The entry is incorrect if interpreted as a molecular target for therapeutic intervention. If you are seeking information on the functional gene and protein, please refer to ALMS1 (centrosome and basal body associated protein), which is linked to Alström syndrome and participates in centrosome, ciliary, and metabolic processes[1][2][4].

Other names
ALMS1LALMS1Pcentrosome and basal body associated protein pseudogene 1Alstrom syndrome 1 pseudogene

Beyond the preview

Go deeper on ALMS1 pseudogene 1 (ALMS1P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ALMS1 pseudogene 1 (ALMS1P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call